Syon Capital LLC Has $502,000 Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Syon Capital LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,853 shares of the company’s stock after purchasing an additional 64 shares during the period. Syon Capital LLC’s holdings in HCA Healthcare were worth $502,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Stone House Investment Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter worth about $25,000. BluePath Capital Management LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth $27,000. Centerpoint Advisors LLC acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at $27,000. Bruce G. Allen Investments LLC bought a new position in HCA Healthcare during the fourth quarter valued at about $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC bought a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $30,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 2.4 %

Shares of NYSE:HCA opened at $306.60 on Friday. The company has a debt-to-equity ratio of 35.07, a quick ratio of 1.02 and a current ratio of 1.18. The company has a market capitalization of $81.09 billion, a PE ratio of 16.15, a P/E/G ratio of 1.51 and a beta of 1.65. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $335.83. The company’s fifty day moving average is $323.94 and its 200-day moving average is $295.00.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. The company had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The business’s revenue was up 11.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.93 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 20.58 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s dividend payout ratio is currently 13.91%.

HCA Healthcare declared that its Board of Directors has initiated a share buyback plan on Tuesday, January 30th that permits the company to buyback $6.00 billion in shares. This buyback authorization permits the company to reacquire up to 7.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on HCA shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $335.00 price objective on shares of HCA Healthcare in a report on Wednesday, April 10th. Truist Financial boosted their price objective on HCA Healthcare from $320.00 to $345.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Barclays began coverage on HCA Healthcare in a report on Wednesday, March 6th. They set an “overweight” rating and a $356.00 price target for the company. Sanford C. Bernstein lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating and boosted their target price for the stock from $277.00 to $301.00 in a research report on Thursday, January 4th. Finally, Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research report on Thursday, March 28th. Four analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $310.88.

Insiders Place Their Bets

In other news, SVP Kathryn A. Torres sold 3,861 shares of the company’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the transaction, the senior vice president now owns 15,899 shares of the company’s stock, valued at $4,880,993. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 3,861 shares of the company’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the transaction, the senior vice president now directly owns 15,899 shares in the company, valued at approximately $4,880,993. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 3,200 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $306.79, for a total transaction of $981,728.00. Following the sale, the executive vice president now directly owns 24,929 shares of the company’s stock, valued at $7,647,967.91. The disclosure for this sale can be found here. In the last quarter, insiders have sold 14,840 shares of company stock valued at $4,588,869. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.